loader
Delivery Location

PF-06826647 5mg

CAS# 2127109-84-4

Grade: HPLC-UV

SKU: ChemD-976-S9676-5mg-1x5-Milligram-2127109-84-4

Product Overview

In stock
Purity
97%
Size
1x5 Milligram
Container Type
Vial
Est Delivery Date
Price per Unit
Tooltip icon
Quantity
Price per Unit
Tooltip icon
Quantity
Document Links
SDS Document
Form
Not Specified
Density
-
Appearance & Physical State
-
Color
-
Odor
-
Melting Point
-
Boiling Point
-
Freezing Point
-
Molecular Weight
383.41
Flash Point
-
pH value
-

Have a question regarding this product?

Contact Us

Shop all of the products from this supplier?

View Supplier Storefront
Country of Manufacture
-
Refractive Index
-
LogP
-0.4
Exact/Molecular Mass
383.16069158 g/mol
Molar mass
-
Concentration
-
Water Content
-
Acid Content
-
Viscosity
-
Cloud Point
-
Specific heat of liquid
-
Thermo Stability
-
Oxygen Stability
-
Water Stability
-
Vapor Pressure
-
Assay (Gas chromatography)
-
Molecular formula
C20H17N9
Soluble
-
Max Handling Temp
-
Recommended Dosage
-

PF-06826647 5mg for Sale Online

Selleck Chemicals LLC manufactures PF-06826647 5mg, for sale through ChemDirect.
Selleck Chemicals LLC sells PF-06826647 5mg with a product grade of HPLC-UV and percent purity of 97%. PF-06826647 5mg is for sale online in 1x25 Milligram, and 1x5 Milligram quantities. PF-06826647 5mg has the molecular formula C20H17N9 and a chemical weight of 383.41. PF-06826647 5mg is also called tyk2-in-9, pf-06826647, (1r\\, 3r)-3-(cyanomethyl)-3-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1\\, 5-a]pyrazin-4-yl)-1h-pyrazol-1-yl)cyclobutane-1-carbonitrile, schembl19253418, schembl19253420, schembl19271747, schembl19276506, bdbm305820, bdbm305821, bcp33615 and ex-a4020. It's CAS (Chemical Abstracts Service) Registry Number is 2127109-84-4.

Save time and money when you buy PF-06826647 5mg online through ChemDirect.

About the Supplier

Selleck Chemicals LLC Selleck's Bioactive Compound Libraries consist of over 8,000 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research and many of them are FDA-approved compounds.